SUBSCRIBE
SUBSCRIBE

Novartis

NEWS
San Diego's Halozyme Lands Monster R&D Deals Worth $2 Billion+ From Bristol-Myers Squibb and Roche
Deals
Sun Pharma to Acquire Cancer Product from Novartis AG for $175 Million
December 22, 2016
 · 
2 min read
Novartis Unloads Former New York Space for $18 Million, Resold for $30 Million
Deals
Novartis AG Snaps Up Mid-Stage Eczema Rival
December 16, 2016
 · 
3 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Drug Development
Ophthotech Plunges as Wet AMD Drug Combo Trials With Novartis AG Flops in Phase III Studies
December 12, 2016
 · 
2 min read
Deals
Novartis AG the Latest to Join the Asset-Selling Party as it Looks to Offload $496 Million CNS Drugs
December 8, 2016
 · 
1 min read
Deals
Novartis AG CEO Plays Down Prospects For Actelion Bid
December 7, 2016
 · 
1 min read
Novartis to Hold On to Its 33% Stake in Roche—For Now
Business
So Long, Farewell: Head of Novartis AG’s Shuttered CAR-T Unit to Helm Biotech Upstart Tmunity
December 7, 2016
 · 
2 min read
Novartis to Hold On to Its 33% Stake in Roche—For Now
Drug Development
Novartis AG’ CAR-T Drug Sends 82% of Patients’ Blood Cancer into Remission, Eyes 2017 for Marketing
December 5, 2016
 · 
2 min read
Deals
Novartis AG Rumored to be Exploring Sale of Ritalin, Clozaril and Exelon, Deal Could Bring in $300 Million
November 23, 2016
 · 
1 min read
Business
‘Retired’ Former Novartis AG R&D Cancer Head Returns for a New Gig at the Dana-Farber Cancer Institute
November 23, 2016
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Drug Development
Novartis AG Drug Works to Treat Rare Cushing’s Disease
November 5, 2012
 · 
1 min read
Novartis AG Considers Investment in Malaysia
November 5, 2012
 · 
1 min read
Drug Development
Data in The New England Journal of Medicine Show Novartis AG Drug Aclasta® Significantly Reduced the Risk of Fracture in Men With Osteoporosis With Once-Yearly Infusion
November 1, 2012
 · 
10 min read
Precautionary Holds on Novartis AG’ Influenza Vaccines Lifted in Canada, Switzerland
November 1, 2012
 · 
1 min read
Business
Novartis AG to Invest $500 Million in New Singapore Site
October 31, 2012
 · 
1 min read
France Halts Sale of Novartis AG Flu Vaccine, Germany Orders Recall
October 26, 2012
 · 
1 min read
Drug Development
Novartis AG Cannibalizes Gleevec to Boost New Cancer Drug
October 26, 2012
 · 
1 min read
FDA
Novartis AG Drug Certican® Approved by European Health Authorities to Prevent Organ Rejection in Adult Liver Transplant Patients
October 25, 2012
 · 
10 min read
Recently Launched Products Support Novartis AG Sales in Third Quarter, Offsetting Patent Expiry; Pharmaceuticals Well-Positioned With Further Pipeline Progress
October 25, 2012
 · 
1 min read
Novartis AG Delays Restarting Nebraska Factory
October 25, 2012
 · 
1 min read
Load More